183 related articles for article (PubMed ID: 32247283)
1. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
3. Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.
Calvo-Lerma J; Hulst J; Boon M; Colombo C; Masip E; Ruperto M; Fornés-Ferrer V; van der Wiel E; Claes I; Garriga M; Roca M; Crespo-Escobar P; Bulfamante A; Woodcock S; Martínez-Barona S; Andrés A; de Boeck K; Ribes-Koninckx C;
PLoS One; 2019; 14(3):e0213216. PubMed ID: 30861039
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.
Calvo-Lerma J; Boon M; Colombo C; de Koning B; Asseiceira I; Garriga M; Roca M; Claes I; Bulfamante A; Walet S; Pereira L; Ruperto M; Masip E; Asensio-Grau A; Giana A; Affourtit P; Heredia A; Vicente S; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
J Cyst Fibros; 2021 Sep; 20(5):e33-e39. PubMed ID: 33279468
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Woestenenk JW; van der Ent CK; Houwen RH
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
7. Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.
Wouthuyzen-Bakker M; Bodewes FA; Verkade HJ
J Cyst Fibros; 2011 May; 10(3):150-8. PubMed ID: 21459688
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption.
Calvo-Lerma J; Martínez-Barona S; Masip E; Fornés V; Ribes-Koninckx C
Rev Esp Enferm Dig; 2017 Oct; 109(10):684-689. PubMed ID: 28747058
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
[TBL] [Abstract][Full Text] [Related]
10. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study.
Weintraub A; Blau H; Mussaffi H; Picard E; Bentur L; Kerem E; Stankiewicz H; Wilschanski M
J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):306-10. PubMed ID: 19274786
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
[TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
Roca M; Masip E; Colombo C; Boon M; Hulst JM; Garriga M; de Koning BAE; Bulfamante A; de Boeck K; Ribes-Koninckx C; Calvo-Lerma J
Arch Dis Child; 2024 Jun; 109(7):552-556. PubMed ID: 38123920
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
Walkowiak J; Herzig KH; Strzykala K; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M
Med Wieku Rozwoj; 2003; 7(2):149-55. PubMed ID: 12878785
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
[TBL] [Abstract][Full Text] [Related]
15. How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis.
Larriba R; Roca M; Masip E; Cañada-Martínez A; Ribes-Koninckx C; Calvo-Lerma J
Dig Liver Dis; 2023 Apr; 55(4):513-518. PubMed ID: 36435715
[TBL] [Abstract][Full Text] [Related]
16. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
[TBL] [Abstract][Full Text] [Related]
17. Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.
Borowitz D; Goss CH; Limauro S; Konstan MW; Blake K; Casey S; Quittner AL; Murray FT
J Pediatr; 2006 Nov; 149(5):658-662. PubMed ID: 17095338
[TBL] [Abstract][Full Text] [Related]
18. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
[TBL] [Abstract][Full Text] [Related]
19. Dependence of PERT endpoint on endogenous lipase activity.
Gao WY; Mulberg AE
Pancreas; 2014 Nov; 43(8):1232-8. PubMed ID: 25102439
[TBL] [Abstract][Full Text] [Related]
20. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Alkaade S; Vareedayah AA
Am J Manag Care; 2017 Jul; 23(12 Suppl):S203-S209. PubMed ID: 28727474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
